AVTR
Undervalued by 109.3% based on the discounted cash flow analysis.
Market cap | $9.18 Billion |
---|---|
Enterprise Value | $10.70 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $1.05 |
Beta | 0.96 |
Outstanding Shares | 681,500,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 13.35 |
---|---|
PEG | -1.35 |
Price to Sales | -13.31 |
Price to Book Ratio | 1.48 |
Enterprise Value to Revenue | -15281.03 |
Enterprise Value to EBIT | 28.05 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0.18 |
Debt to Equity | 0.31 |
No data
No data
Avantor?, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.